tradingkey.logo

Inspire Medical Systems Inc

INSP
95.390USD
-0.260-0.27%
收盘 12/26, 16:00美东报价延迟15分钟
2.77B总市值
63.63市盈率 TTM

Inspire Medical Systems Inc

95.390
-0.260-0.27%

关于 Inspire Medical Systems Inc 公司

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Inspire Medical Systems Inc简介

公司代码INSP
公司名称Inspire Medical Systems Inc
上市日期May 03, 2018
CEOHerbert (Timothy P)
员工数量1246
证券类型Ordinary Share
年结日May 03
公司地址5500 Wayzata Blvd Ste 1600
城市GOLDEN VALLEY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编55416-1237
电话17639575037
网址https://www.inspiresleep.com/
公司代码INSP
上市日期May 03, 2018
CEOHerbert (Timothy P)

Inspire Medical Systems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
27.85K
-4.13%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.23K
+0.96%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.37K
+5.94%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-0.12%
Mr. John C. Rondoni
Mr. John C. Rondoni
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Carlton W. Weatherby
Mr. Carlton W. Weatherby
Chief Strategy and Growth Officer
Chief Strategy and Growth Officer
--
--
Ms. Georgia Garinoismelenikiotou
Ms. Georgia Garinoismelenikiotou
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-79.27%
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
27.85K
-4.13%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.23K
+0.96%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-43.33%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
--
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.37K
+5.94%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
207.15M
95.42%
All other countries
9.94M
4.58%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.30%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
William Blair Investment Management, LLC
4.47%
其他
63.29%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.30%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
William Blair Investment Management, LLC
4.47%
其他
63.29%
股东类型
持股股东
占比
Investment Advisor
48.25%
Hedge Fund
27.37%
Investment Advisor/Hedge Fund
25.26%
Research Firm
6.21%
Pension Fund
2.32%
Individual Investor
1.19%
Sovereign Wealth Fund
0.96%
Bank and Trust
0.81%
Venture Capital
0.42%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
2023Q2
727
29.57M
101.94%
-987.85K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.49M
11.8%
-108.13K
-3.00%
Jun 30, 2025
The Vanguard Group, Inc.
3.20M
10.81%
-22.12K
-0.69%
Jun 30, 2025
William Blair Investment Management, LLC
769.17K
2.6%
+76.25K
+11.00%
Jun 30, 2025
Baillie Gifford & Co.
1.11M
3.77%
-45.87K
-3.95%
Jun 30, 2025
State Street Investment Management (US)
1.03M
3.49%
+22.84K
+2.27%
Jun 30, 2025
Braidwell LP
522.41K
1.77%
+220.00K
+72.75%
Jun 30, 2025
Janus Henderson Investors
640.92K
2.17%
-1.84K
-0.29%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
查看更多
Global X HealthTech ETF
占比2.68%
State Street SPDR S&P Health Care Equipment ETF
占比1.63%
Invesco S&P SmallCap Health Care ETF
占比1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.53%
iShares S&P Small-Cap 600 Growth ETF
占比0.43%
VictoryShares Small Cap Free Cash Flow ETF
占比0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
占比0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.27%
WisdomTree US SmallCap Quality Growth Fund
占比0.26%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Inspire Medical Systems Inc的前五大股东是谁?

Inspire Medical Systems Inc 的前五大股东如下:
BlackRock Institutional Trust Company, N.A.持有股份:3.49M,占总股份比例:11.80%。
The Vanguard Group, Inc.持有股份:3.20M,占总股份比例:10.81%。
William Blair Investment Management, LLC持有股份:769.17K,占总股份比例:2.60%。
Baillie Gifford & Co.持有股份:1.11M,占总股份比例:3.77%。
State Street Investment Management (US)持有股份:1.03M,占总股份比例:3.49%。

Inspire Medical Systems Inc的前三大股东类型是什么?

Inspire Medical Systems Inc 的前三大股东类型分别是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Citadel Advisors LLC

有多少机构持有Inspire Medical Systems Inc(INSP)的股份?

截至2025Q3,共有828家机构持有Inspire Medical Systems Inc的股份,合计持有的股份价值约为32.29M,占公司总股份的111.12%。与2025Q2相比,机构持股有所增加,增幅为-8.85%。

哪个业务部门对Inspire Medical Systems Inc的收入贡献最大?

在FY2025Q2,--业务部门对Inspire Medical Systems Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI